Corrigendum | Open Access
Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior, Paulo Dalgalarrondo, "Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”", International Journal of Endocrinology, vol. 2017, Article ID 8165368, 1 page, 2017. https://doi.org/10.1155/2017/8165368
Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
In the article titled “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents” , there was an error in the “Laboratory Evaluation” section, where the selected CYP2D6 SNP is written as rs72552269, and should be corrected to “rs1065852.”
- A. D. Santos-Júnior, T. B. Henriques, M. P. de Mello et al., “Pharmacogenetics of risperidone and cardiovascular risk in children and adolescents,” International Journal of Endocrinology, vol. 2016, Article ID 5872423, 10 pages, 2016.
Copyright © 2017 Amilton Dos Santos-Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.